Mode of Action

Lorem ipsum dolor sit amet, probo tantas commune at mea, te est vidisse perfecto adipiscing, id tota admodum efficiendi has. Assum honestatis ne vim.

Clinical Trials

Lorem ipsum dolor sit amet, probo tantas commune at mea, te est vidisse perfecto adipiscing, id tota admodum efficiendi has. Assum honestatis ne vim.

Lung Function

Lorem ipsum dolor sit amet, probo tantas commune at mea, te est vidisse perfecto adipiscing, id tota admodum efficiendi has. Assum honestatis ne vim.

Patient

Lorem ipsum dolor sit amet, probo tantas commune at mea, te est vidisse perfecto adipiscing, id tota admodum efficiendi has. Assum honestatis ne vim.Sanofi to provide teaser content

Dosing

Lorem ipsum dolor sit amet, probo tantas commune at mea, te est vidisse perfecto adipiscing, id tota admodum efficiendi has. Assum honestatis ne vim.Sanofi to provide teaser copy 

Resources

Lorem ipsum dolor sit amet, probo tantas commune at mea, te est vidisse perfecto adipiscing, id tota admodum efficiendi has. Assum honestatis ne vim.

References

  1. Australian Approved Product Information for Dupixent (dupilumab). 6 October 2020.
  2. Boguniewicz et al. Ann Allergy Asthma Immunol 2018: 120: 10–22.